Chung‐Jen Yen

Molecular Scanning of the Human Peroxisome Proliferator Activated Receptor γ (hPPARγ) Gene in Diabetic Caucasians: Identification of a Pro12Ala PPARγ2 Missense Mutation

Chung‐Jen Yen, Brock A. Beamer, Carlo Negri et al. · Biochemical and Biophysical Research Communications · 1997 · 491 citations · Full text

Two Decades of Universal Hepatitis B Vaccination in Taiwan: Impact and Implication for Future Strategies

Yen‐Hsuan Ni, Li‐Min Huang, Mei‐Hwei Chang et al. · Gastroenterology · 2007 · 346 citations · Full text

Vaccination, Future Strategies, Infectious Disease Prevention +10

Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations.

Brock A. Beamer, Chung‐Jen Yen, Ross E. Andersen et al. · Diabetes · 1998 · 293 citations

Metabolic Disorder, Pathology, Caloric Restriction +24

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO

L.-T. Chen, Erika Martinelli, Ann‐Lii Cheng et al. · Annals of Oncology · 2020 · 233 citations

Hepatology, Medicine, Cancer Management +11

A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer

J.S. Chen, Chih‐Hung Hsu, Nai‐Jung Chiang et al. · Annals of Oncology · 2015 · 157 citations

Gastrointestinal Oncology, Medicine, Biliary Cancer +7